Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Matt Huentelman, Glen Weiss

Premium

Matt Huentelman and Glen Weiss are among the 40 business leaders under 40 years of age named by the Phoenix Business Journal to its 13th annual Class of 40 Under 40.

Huentelman is an associate professor at the Translational Genomics Research Institute's neurogenomics division and co-director of TGen's Center for Rare Childhood Disorders.

Weiss is a clinical associate professor in TGen's cancer and cell biology division, co-unit head of TGen's lung cancer research laboratory, and the director of clinical research at the Cancer Treatment Centers of America. In addition, CTCA at Western Regional Medical Center has named him to head the new clinical research program in Goodyear, Ariz.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.